Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2002

View Archived Issues

Telomerase inhibitors under study at Pharmacia

Novel 5-HT6 ligands for depression, anxiety, cognitive disorders, etc., claimed in recent patent

AstraZeneca team identifies kappa opioid agonists

TLK-286 enters two new combination trials

Amended phase II protocol for FM-VP4

Argenta Discovery and Amedis extend collaboration

Provectus acquires company recently split from Photogen

Milnacipran improves FMS pain and fatigue in preliminary analysis

Phase III Ampligen trial in CFS completes enrollment

Paladin returns Canadian DepoCyt rights to SkyePharma

Pharmexa and Lundbeck Alzheimer's collaboration achieves proof of concept in animals

Minimal toxicity reported for SGN-30 in Hodgkin's disease and lymphoma

Potential use of MLN-518 in AML and high-risk MDS

Significant improvement reported on eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Reduced liver iron content in thalassemic patients treated with ICL-670

Comparison of warfarin and idraparinux sodium in deep vein thrombosis

New cephem antibiotics discovered jointly by Fujisawa and Wakunaga

Series of 5-HT1A antagonists in early development at Wyeth

KuDOS and Maybridge claim isoquinoline-based PARP inhibitors

New tyrosine kinase inhibitors and their use in proliferative disorders

Veronate granted fast track status

Helix BioPharma completes acquisition of minority interest in Sensium

Medicure enters research collaboration with university group for NHE inhibitors

GSK identifies novel 5-HT7 receptor antagonist with good pharmacokinetic properties

Fully human MAb to human VEGFR-3 designed at ImClone Systems

Pharmacological profile of VX-944, an IMPDH inhibitor, characterized at ASH meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...